[
  {
    "ts": null,
    "headline": "Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Stock That Seems To Have Disappointed People. Bizarre’",
    "summary": "We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other stocks. In one of his latest appearances on CNBC’s Squawk on the Street, Jim Cramer started the morning […]",
    "url": "https://finnhub.io/api/news?id=871a48ffc85b09fcca467e7efb13a50d299218ab09d196c58527d1aa14eab4fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736958541,
      "headline": "Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Stock That Seems To Have Disappointed People. Bizarre’",
      "id": 132439110,
      "image": "https://s.yimg.com/ny/api/res/1.2/jMekiCT4mZ2_S7szsjNT5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other stocks. In one of his latest appearances on CNBC’s Squawk on the Street, Jim Cramer started the morning […]",
      "url": "https://finnhub.io/api/news?id=871a48ffc85b09fcca467e7efb13a50d299218ab09d196c58527d1aa14eab4fc"
    }
  },
  {
    "ts": null,
    "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
    "summary": "NEW YORK, Jan. 15, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron...",
    "url": "https://finnhub.io/api/news?id=5bbd35e77796cbf204fcbf7660b200c5fb167a3dc47ddb489fb67ccc710f012d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736948945,
      "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
      "id": 132400897,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Jan. 15, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron...",
      "url": "https://finnhub.io/api/news?id=5bbd35e77796cbf204fcbf7660b200c5fb167a3dc47ddb489fb67ccc710f012d"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?",
    "summary": "It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...",
    "url": "https://finnhub.io/api/news?id=0d46c4026cfd06851368cbcb709f260a04290abae255c8fbf27a2a090207ee42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736938822,
      "headline": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?",
      "id": 132439111,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...",
      "url": "https://finnhub.io/api/news?id=0d46c4026cfd06851368cbcb709f260a04290abae255c8fbf27a2a090207ee42"
    }
  },
  {
    "ts": null,
    "headline": "SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals",
    "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Regeneron To Contact Him Directly To Discuss Their OptionsIf you...",
    "url": "https://finnhub.io/api/news?id=5a0b3c4613791fb896a1a0c31c716f79ecc579ceebed2af2d1432301bfade9f6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736937306,
      "headline": "SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals",
      "id": 132400083,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Regeneron To Contact Him Directly To Discuss Their OptionsIf you...",
      "url": "https://finnhub.io/api/news?id=5a0b3c4613791fb896a1a0c31c716f79ecc579ceebed2af2d1432301bfade9f6"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron: Phase III Success In Skin Cancer For Libtayo",
    "summary": "Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating REGN stock with a buy rating.",
    "url": "https://finnhub.io/api/news?id=33c846b2ad9b0efa1662937482989a9d414d14a6b8f04a1376c8e8505345785c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736929800,
      "headline": "Regeneron: Phase III Success In Skin Cancer For Libtayo",
      "id": 132399997,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1437090427/image_1437090427.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating REGN stock with a buy rating.",
      "url": "https://finnhub.io/api/news?id=33c846b2ad9b0efa1662937482989a9d414d14a6b8f04a1376c8e8505345785c"
    }
  }
]